載入...
Long-term benefits of omalizumab in a patient with severe non-allergic asthma
INTRODUCTION: Currently, omalizumab is indicated for the treatment of patients with severe allergic uncontrolled asthma despite optimal therapy. CASE PRESENTATION: We studied a 52-year-old man who has been suffering from severe non allergic steroid-resistant asthma with increased levels of total IgE...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3126749/ https://ncbi.nlm.nih.gov/pubmed/21609447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1710-1492-7-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|